The effects of chronic SRIH-14 and octreotide administration on the pituitary-adrenal axis in adult male rats

European Journal of Histochemistry

Volumn 52, Issue 1, 2008, Pages 61-68

  Trifunović, Svetlana ^a   Filipovic B ^a   Ajdzanovic V ^a   Sosic Jurijevic B ^a   Manojlovic Stojanoski M ^a   Nestorovic N ^a   Ristic N ^a   Sekulic M ^a   Milosevic V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

ACTH cells; Adrenal gland; Octreotid; SRIH 14; Stereology

Indexed keywords

ALDOSTERONE; CORTICOSTERONE; CORTICOTROPIN; OCTREOTIDE; SANDOSTATINE; SOMATOSTATIN; UNCLASSIFIED DRUG;

ACTH SECRETING CELL; ADRENAL CORTEX; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DENSITY; CELL NUCLEUS; CELL STRUCTURE; CELL VOLUME; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; ORGAN WEIGHT; RAT; ZONA FASCICULATA; ZONA GLOMERULOSA; ANIMAL; BLOOD; DRUG EFFECT; METABOLISM; ORGAN SIZE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANIMALS; CORTICOTROPHS; MALE; OCTREOTIDE; ORGAN SIZE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; SOMATOSTATIN;

EID: 48249120406     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/1187     Document Type: Article

References (45)

1. Aguilera G, Harwood JP, Catt KJ. Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature 1981;292:262-263 (Pubitemid 11001847)
2. Aguilera G, Parker DS, Catt KJ. Characterization of somatostatin receptors in the rat adrenal glomerulosa zone. Endocrinology 1982;111:1376-1384
3. + retention in portal hypertensive rats. Gastroenterology 1993;104:575-579
4. Andersen M, Hansen TB, Bollerslev J, Bjerre P, Schroder HD, Hagen C. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo- controlled cross-over study. J Endocrinol Invest 1995;18:840-846 (Pubitemid 26064020)
5. Arnold R, Linkisch BG. Somatostatin and gastrointestinal tract. Clin Gastroenterol 1980;9:733-753
6. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, et al. SMS 201-995 a very potent selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133-1140 (Pubitemid 13243115)
7. 2+ in rat lactotrops. Acta Physiol Scand 1988;133:271-282
8. Boscaro M, Scaroni C, Edwards CR, Mantero F. Inhibitory effect of somatostatin on the aldosterone response to angiotenzin II: in vitro studies. J Endocrinol Invest 1982;5:173-177 (Pubitemid 12011749)
9. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79
10. Brown MR, Rivier C, Vale W. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. Endocrinology 1984;114:1546-1549 (Pubitemid 14140301)
11. Day R, Dong W, Panetta R, Krajcer J, Greenwood MT, Patel YC. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 1995;136:5232-5235
12. de Bruin TWA, Kwekkeboom DJ, Van't Verlaat JW, et al. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-1317
13. Epelbaum J, Dournaud P, Fodor M, Viollet C. The neurobiology of somatostatin. Crit Rev Neurobiol 1994;8:25-44. (Pubitemid 24024904)
14. Epelbaum J, Bertherat J, Prevost G, Kordon C, Meyerhof W, Wulfsen I, et al. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 1995;80:1837-1844
15. Kalamokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, et al. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J gastroenterol 2005;100:879-885
16. Lamberts SW, Reubi JC, Uitterlinden P, Zuiderwijk J, van den Werff P, Van Hal P. Studies on mechanism of action of the inhibitory effect of somatostatin analog SMS 201-995 on growth of prolactin/adrenocorticotropin-secreting tumor 7315a. Endocrinology 1986;118:2188-2194 (Pubitemid 16058382)
17. Lamberts SW, Zuyderwijk J, den Holder F, van Koetsveld P, Hofland L. Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin in release by cultured rat pituitary cells. Neuroendocrinology 1989;50:44-50. (Pubitemid 19152163)
18. Lamberts SW, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991;12:450-482
19. Lieverse J, Jansen J, Masclee A, Lamers C. Effects of somatostatin on human satiety. Neuroendocrinology 1995;61:112-116
20. Maurer R, Reubi JC. Somatostatin receptors in the adrenal. Mol Cell Endocrinol 1986;45:81-90. (Pubitemid 16125097)
21. Mazzocchi G, Robba C, Rebuffat P, Nussdorfer GC. Effects of prolactin administration on the zona glomerulosa of the rat adrenal cortex: stereology and plasma hormone concentrations Acta Endocrinol 1986;111:101-105
22. Miloševic V, Brkic B, Velkovski S, Starcevic V. Somatostatin-induced changes of the ACTH and STH cells in the hypophysis of the male rats. Yugoslav Med Biohem 1994;13:102-106
23. Miloševic V, Velkovski S, Brkic B, Sekulic M, Lovren M, Starcevic V, Severs WB. Inhibitory effects of centrally administered somatostatin on the adrenal zona glomerulosa in a male rats. Pharmacology 1996;53:369-375 (Pubitemid 27047293)
24. Miloševic V, Brkic B, Velkovski S, Sekulic M, Lovren M, Starcevic V, et al. Morphometric and functional changes of the rat pituitary somatotropes and lactotropes after central administration of somatostatin. Pharmacology 1998;57:28-34. (Pubitemid 28288866)
25. Miloševic V, Sekulic M, Brkic B, Lovren M, Starcevic V. Effect of centrally administered somatostatin on pituitary thyreotropes in male rats. Histochem J 2000;32:565-569 (Pubitemid 30943631)
26. Miloševic V, Manojlovic M, Kostic N, Brkic B, Velkovski S, Šošic-Jurjevic B, et al. A somatostatin analogue octreotide inhibits pituitary ACTH cells in rat males. Iugoslav Physiol Pharmacol Acta 2003;39(1):25-30.
27. Miloševic V, Nestorovic N, Filipovic B, Velkovski S, Starcevic V. Centrally applied somatostatin influences morphology of pituitary FSH cells but not FSH release. Gen Physiol Biophys 2004;23:375-380 (Pubitemid 39489824)
28. Nestorovic N, Lovren M, Sekulic M, Filipovic B, Miloševic V. Effects of multiple somatostatin treatment on rat gonadotrophic cells and ovaries. Histochem J 2001;33:695-702. (Pubitemid 34852238)
29. Nicholson SA, Adrian TE, Gillham B, Jones MT, Bloom SR. Effect of hypothalamic neuropeptides on corticotrophin release from quarters of rat anterior pituitary gland in vitro. J Endocrinol 1984;100:219-226 (Pubitemid 14193961)
30. O'Carroll AM, Krempels K. Widespread distribution of somatostatin messenger ribonucleic acid in rat pituitary. Endocrinology 1995;136:5224-5227
31. O'Carroll AM. Localization of messenger ribonucleic acids for somatostatin receptor subtypes (sstr1-5) in the rat adrenal gland. J Histochem Cytochem 2003;51:55-60. (Pubitemid 36133486)
32. Patel YC. Somatostatin and its Receptor Family. Front Neuroendocrinol 1999;20:157-198
33. Rebuffat P, Robba C, Mazzocchi G, Nussdorfer GC. Inhibitory effect of somatostatin on the growth and steroidogenic capacity of rat adrenal zona glomerulosa. J Steroid Biochem 1984;21:387-390 (Pubitemid 15200539)
34. Rebuffat P, Robba C, Mazzocchi G, Nussdorfer GG. Further studies on the effects of prolonged prolactin administration on the zona glomerulosa of the rat andrenal cortex. Res Exp Med 1986;186:307-315 (Pubitemid 16047880)
35. Reichlin S. Somatostatin. N Engl J Med 1983a;309:1495-1501
36. Reichlin S. Somatostatin (second of two parts). N Engl J Med 1983b;309:1556-1563
37. Richardon UI, Schonbrunn A. Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture. Endocrinology 1981;108:281-290 (Pubitemid 11212830)
38. Rossowski WJ, Coy DH. Specific inhibition of rat pancreatic insulin or glucagons release by receptor-selective somatostatin analogs. Biochem Biophys Res Commun 1994;205:341-346 (Pubitemid 24381631)
39. Sabat M, Guarner C, Soriano G, Bulbena O, Novella MT, Ortiz J, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sc 1998;43:2184-2189 (Pubitemid 28487245)
40. Scalera G, Tarozzi G. Somatostatin administration modifies food intake, body weight, and gat motility in rat. Peptides 1998;19: 991-997 (Pubitemid 28383794)
41. Starcevic V, Miloševic V, Brkic B, Severs WB. Somatostatin affects morphology and secretion of pituitary luteinizing hormone (LH) cells in male rats. Life Sci 2002;70:3019-3027 (Pubitemid 34442700)
42. Sternberger LA, Hardy PHJr, Cuculius JJ, Meyer HG. The unlabelled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970;18:315-333
43. Swinyard C. Methods for volumetric determination of fresh endocrine gland. The anatomical record 1938;74:71-78
44. Vinson G, Whitehouse B, Dell A, Etienne T, Morris H. Characterisation of on adrenal zona glomerulosa-stimulating component of posterior pituitary extracts as λ-MSH. Nature 1980;284:464-467 (Pubitemid 10121325)
45. Weibel ER. Stereological methods. Vol 1. Practical methods for biological morphometry. Academic Press, London 1979, pp. 1-415.